会員登録
ログイン
【4151】協和キリン
医薬品、バイオケミカル。親会社はキリンHLD。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.12 | 2024/10/31 | Q3予 | 492,000 | → | 0.0% | +4.0% | 92,000 | → | 0.0% | +8.2% | 92,000 | → | 0.0% | +8.2% | 68,000 | → | 0.0% | +7.9% |
| 2024.12 | 2024/08/01 | Q2予 | 492,000 | ↑ | +4.0% | +4.0% | 92,000 | ↑ | +8.2% | +8.2% | 92,000 | ↑ | +8.2% | +8.2% | 68,000 | ↑ | +7.9% | +7.9% |
| 2024.12 | 2024/05/07 | Q1予 | 473,000 | → | 0.0% | 0.0% | 85,000 | → | 0.0% | 0.0% | 85,000 | → | 0.0% | 0.0% | 63,000 | → | 0.0% | 0.0% |
| 2024.12 | 2024/02/07 | 当初予 | 473,000 | - | - | - | 85,000 | - | - | - | 85,000 | - | - | - | 63,000 | - | - | - |
| 2023.12 | 2024/02/07 | 実 | 442,233 | ↑ | +3.8% | +3.8% | 97,246 | ↑ | +13.1% | +3.5% | 97,246 | ↑ | +13.1% | +3.5% | 81,188 | ↑ | +16.0% | +6.8% |
| 2023.12 | 2023/11/01 | Q3予 | 426,000 | → | 0.0% | 0.0% | 86,000 | → | 0.0% | -8.5% | 86,000 | → | 0.0% | -8.5% | 70,000 | → | 0.0% | -7.9% |
| 2023.12 | 2023/08/03 | Q2予 | 426,000 | → | 0.0% | 0.0% | 86,000 | → | 0.0% | -8.5% | 86,000 | → | 0.0% | -8.5% | 70,000 | → | 0.0% | -7.9% |
| 2023.12 | 2023/05/10 | Q1予 | 426,000 | → | 0.0% | 0.0% | 86,000 | ↓ | -8.5% | -8.5% | 86,000 | ↓ | -8.5% | -8.5% | 70,000 | ↓ | -7.9% | -7.9% |
| 2023.12 | 2023/02/07 | 当初予 | 426,000 | - | - | - | 94,000 | - | - | - | 94,000 | - | - | - | 76,000 | - | - | - |
| 2022.12 | 2023/02/07 | 実 | 398,371 | ↓ | -0.4% | +4.8% | 67,572 | ↑ | +4.0% | +2.4% | 67,572 | ↑ | +4.0% | +2.4% | 53,573 | ↑ | +1.1% | +1.1% |
| 2022.12 | 2022/12/06 | 修正予 | 400,000 | → | 0.0% | +5.3% | 65,000 | ↓ | -1.5% | -1.5% | 65,000 | ↓ | -17.7% | -1.5% | 53,000 | ↓ | -15.9% | 0.0% |
| 2022.12 | 2022/11/04 | Q3予 | 400,000 | → | 0.0% | +5.3% | - | - | - | - | 79,000 | → | 0.0% | +19.7% | 63,000 | → | 0.0% | +18.9% |
| 2022.12 | 2022/08/04 | Q2予 | 400,000 | ↑ | +5.3% | +5.3% | - | - | - | - | 79,000 | ↑ | +19.7% | +19.7% | 63,000 | ↑ | +18.9% | +18.9% |
| 2022.12 | 2022/05/10 | Q1予 | 380,000 | → | 0.0% | 0.0% | - | - | - | - | 66,000 | → | 0.0% | 0.0% | 53,000 | → | 0.0% | 0.0% |
| 2022.12 | 2022/02/07 | 当初予 | 380,000 | - | - | - | 66,000 | - | - | - | 66,000 | - | - | - | 53,000 | - | - | - |
| 2021.12 | 2022/02/07 | 実 | 352,246 | ↑ | +0.4% | +0.4% | 60,050 | ↓ | -7.6% | -6.2% | 60,050 | ↓ | -6.2% | -6.2% | 52,347 | ↑ | +4.7% | +4.7% |
| 2021.12 | 2021/11/01 | Q3予 | 351,000 | → | 0.0% | 0.0% | 65,000 | ↑ | +1.6% | +1.6% | 64,000 | → | 0.0% | 0.0% | 50,000 | → | 0.0% | 0.0% |
| 2021.12 | 2021/08/03 | Q2予 | 351,000 | → | 0.0% | 0.0% | - | - | - | - | 64,000 | → | 0.0% | 0.0% | 50,000 | → | 0.0% | 0.0% |
| 2021.12 | 2021/05/06 | Q1予 | 351,000 | → | 0.0% | 0.0% | - | - | - | - | 64,000 | → | 0.0% | 0.0% | 50,000 | → | 0.0% | 0.0% |
| 2021.12 | 2021/02/04 | 当初予 | 351,000 | - | - | - | 64,000 | - | - | - | 64,000 | - | - | - | 50,000 | - | - | - |
| 2020.12 | 2021/02/04 | 実 | 318,352 | ↑ | +1.7% | -2.6% | 52,263 | ↓ | -17.0% | -17.0% | 52,263 | ↓ | -1.4% | -17.0% | 47,027 | ↑ | +6.9% | -4.0% |
| 2020.12 | 2020/10/30 | Q3予 | 313,000 | → | 0.0% | -4.3% | - | - | - | - | 53,000 | → | 0.0% | -15.9% | 44,000 | → | 0.0% | -10.2% |
| 2020.12 | 2020/07/30 | Q2予 | 313,000 | ↓ | -4.3% | -4.3% | - | - | - | - | 53,000 | ↓ | -15.9% | -15.9% | 44,000 | ↓ | -10.2% | -10.2% |
| 2020.12 | 2020/05/01 | Q1予 | 327,000 | → | 0.0% | 0.0% | - | - | - | - | 63,000 | → | 0.0% | 0.0% | 49,000 | → | 0.0% | 0.0% |
| 2020.12 | 2020/02/05 | 当初予 | 327,000 | - | - | - | 63,000 | - | - | - | 63,000 | - | - | - | 49,000 | - | - | - |
| 2019.12 | 2020/02/05 | 実 | 305,820 | ↑ | +0.3% | +0.3% | 44,492 | ↓ | -5.3% | -5.3% | 44,492 | ↓ | -5.3% | -5.3% | 67,084 | ↓ | -1.3% | -1.3% |
| 2019.12 | 2019/10/29 | Q3予 | 305,000 | → | 0.0% | 0.0% | - | - | - | - | 47,000 | → | 0.0% | 0.0% | 68,000 | → | 0.0% | 0.0% |
| 2019.12 | 2019/08/01 | Q2予 | 305,000 | → | 0.0% | 0.0% | - | - | - | - | 47,000 | → | 0.0% | 0.0% | 68,000 | → | 0.0% | 0.0% |
| 2019.12 | 2019/05/08 | Q1予 | 305,000 | → | 0.0% | 0.0% | - | - | - | - | 47,000 | → | 0.0% | 0.0% | 68,000 | → | 0.0% | 0.0% |
| 2019.12 | 2019/02/05 | 当初予 | 305,000 | - | - | - | 47,000 | - | - | - | 47,000 | - | - | - | 68,000 | - | - | - |
| 2018.12 | 2019/02/05 | 実 | 346,531 | ↑ | +3.4% | +3.4% | 73,438 | ↑ | +20.4% | +20.4% | 73,438 | ↑ | +3.4% | +20.4% | 54,414 | ↑ | +4.6% | +23.7% |
| 2018.12 | 2018/10/30 | Q3予 | 335,000 | → | 0.0% | 0.0% | - | - | - | - | 71,000 | ↑ | +16.4% | +16.4% | 52,000 | ↑ | +18.2% | +18.2% |
| 2018.12 | 2018/07/31 | Q2予 | 335,000 | → | 0.0% | 0.0% | - | - | - | - | 61,000 | → | 0.0% | 0.0% | 44,000 | → | 0.0% | 0.0% |
| 2018.12 | 2018/05/08 | Q1予 | 335,000 | → | 0.0% | 0.0% | - | - | - | - | 61,000 | → | 0.0% | 0.0% | 44,000 | → | 0.0% | 0.0% |
| 2018.12 | 2018/02/08 | 当初予 | 335,000 | - | - | - | 61,000 | - | - | - | 61,000 | - | - | - | 44,000 | - | - | - |
| 2017.12 | 2018/02/08 | 実 | 353,380 | ↑ | +1.8% | +2.7% | 55,849 | ↑ | +43.2% | +59.6% | 55,849 | ↑ | +59.6% | +86.2% | 42,899 | ↑ | +104.3% | +125.8% |
| 2017.12 | 2017/10/26 | Q3予 | 347,000 | → | 0.0% | +0.9% | 39,000 | → | 0.0% | +11.4% | 35,000 | → | 0.0% | +16.7% | 21,000 | → | 0.0% | +10.5% |
| 2017.12 | 2017/07/28 | Q2予 | 347,000 | ↑ | +0.9% | +0.9% | 39,000 | ↑ | +11.4% | +11.4% | 35,000 | ↑ | +16.7% | +16.7% | 21,000 | ↑ | +10.5% | +10.5% |
| 2017.12 | 2017/04/27 | Q1予 | 344,000 | → | 0.0% | 0.0% | 35,000 | → | 0.0% | 0.0% | 30,000 | → | 0.0% | 0.0% | 19,000 | → | 0.0% | 0.0% |
| 2017.12 | 2017/01/31 | 当初予 | 344,000 | - | - | - | 35,000 | - | - | - | 30,000 | - | - | - | 19,000 | - | - | - |
| 2016.12 | 2017/01/31 | 実 | 343,019 | ↓ | -0.3% | -2.3% | 31,638 | ↓ | -1.1% | +5.5% | 26,397 | ↑ | +1.5% | -12.0% | 18,669 | ↑ | +3.7% | +16.7% |
| 2016.12 | 2016/10/28 | Q3予 | 344,000 | ↓ | -2.0% | -2.0% | 32,000 | ↑ | +6.7% | +6.7% | 26,000 | ↓ | -13.3% | -13.3% | 18,000 | ↑ | +12.5% | +12.5% |
| 2016.12 | 2016/04/27 | Q1予 | 351,000 | → | 0.0% | 0.0% | 30,000 | → | 0.0% | 0.0% | 30,000 | → | 0.0% | 0.0% | 16,000 | → | 0.0% | 0.0% |
| 2016.12 | 2016/01/29 | 当初予 | 351,000 | - | - | - | 30,000 | - | - | - | 30,000 | - | - | - | 16,000 | - | - | - |
| 2015.12 | 2016/01/29 | 実 | 364,316 | ↑ | +1.2% | +2.9% | 43,765 | ↓ | -6.9% | +5.5% | 39,203 | ↓ | -4.4% | -5.5% | 29,774 | ↑ | +14.5% | +60.9% |
| 2015.12 | 2015/10/28 | Q3予 | 360,000 | → | 0.0% | +1.7% | 47,000 | → | 0.0% | +13.3% | 41,000 | → | 0.0% | -1.2% | 26,000 | → | 0.0% | +40.5% |
| 2015.12 | 2015/07/31 | Q2予 | 360,000 | ↑ | +1.7% | +1.7% | 47,000 | ↑ | +13.3% | +13.3% | 41,000 | ↓ | -1.2% | -1.2% | 26,000 | ↑ | +40.5% | +40.5% |
| 2015.12 | 2015/04/28 | Q1予 | 354,000 | → | 0.0% | 0.0% | 41,500 | → | 0.0% | 0.0% | 41,500 | → | 0.0% | 0.0% | 18,500 | → | 0.0% | 0.0% |
| 2015.12 | 2015/01/30 | 当初予 | 354,000 | - | - | - | 41,500 | - | - | - | 41,500 | - | - | - | 18,500 | - | - | - |
| 2014.12 | 2015/01/30 | 実 | 333,446 | ↓ | -0.8% | -1.1% | 36,173 | ↓ | -15.9% | -11.8% | 29,511 | ↓ | -15.7% | -28.0% | 15,898 | ↓ | -11.7% | -20.5% |
| 2014.12 | 2014/10/28 | Q3予 | 336,000 | ↓ | -0.3% | -0.3% | 43,000 | ↓ | -4.4% | +4.9% | 35,000 | ↓ | -5.4% | -14.6% | 18,000 | ↓ | -10.0% | -10.0% |
| 2014.12 | 2014/07/30 | Q2予 | 337,000 | → | 0.0% | 0.0% | 45,000 | ↑ | +9.8% | +9.8% | 37,000 | ↓ | -9.8% | -9.8% | 20,000 | → | 0.0% | 0.0% |
| 2014.12 | 2014/04/24 | Q1予 | 337,000 | → | 0.0% | 0.0% | 41,000 | → | 0.0% | 0.0% | 41,000 | → | 0.0% | 0.0% | 20,000 | → | 0.0% | 0.0% |
| 2014.12 | 2014/01/31 | 当初予 | 337,000 | - | - | - | 41,000 | - | - | - | 41,000 | - | - | - | 20,000 | - | - | - |
| 2013.12 | 2014/01/31 | 実 | 340,611 | - | - | - | 51,773 | - | - | - | 49,502 | - | - | - | 30,078 | - | - | - |
